TTRX · Categories · Form 4

TTRX - SEC Form 4 insider transactions

Turn Therapeutics Inc. (TTRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TTRX

• 24d
  SEC Form 4 filed by Burnam Bradley Evan

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 24d
  SEC Form 4 filed by Golden Arthur F

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 24d
  SEC Form 4 filed by Burnam Bradley Evan

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 24d
  SEC Form 4 filed by Chaudhary Zuraiz

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 82d
  Director Dewhurst Martin William was granted 21,882 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Chief Medical Officer Ghodadra Neilesh Shailesh was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Kester Kent Edward was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  SEC Form 4 filed by Officer Chaudhary Zuraiz

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Golden Arthur F was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)
• 198d
  Director Gengos Andrew was granted 10,000 shares (SEC Form 4)

  4 - Turn Therapeutics Inc. (0002023016) (Issuer)

Other TTRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends